- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01938963
Chinese Older Adults-Collaboration in Health (COACH)Study (COACH)
The Depression/Hypertension in Chinese Older Adults-Collaboration in Health
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The Depression/Hypertension in Chinese Older Adults - Collaborations in Health (COACH) Study is a randomized controlled trial (RCT) comparing the COACH intervention to care as usual (CAU) for the treatment of comorbid depression and hypertension (HTN) in Chinese older adult rural village residents. COACH integrates the care provided by the older person's primary care provider (PCP) with that delivered by an Aging Worker (AW; a lay member of the village's Aging Association), supervised by a psychiatrist consultant. Based on chronic disease management principles, the PCP is trained to use evidence based practice guidelines for treatment of both HTN and depression, and provided with access to mental health consultation regarding optimal management of the patient's depression. The AW is trained to conduct a systematic assessment of the older person's social context to identify and reduce social and environmental barriers to treatment adherence and response. AWs participate with the PCP in developing multidisciplinary care plans for their shared patients, reinforce treatment adherence and adoption of healthy behaviors, and emphasize activation and engagement of the older person in activities designed to improve their connectedness to others and to the community. Finally, PCP, AW, and Psychiatrist Consultant are trained to collaborate in their shared clients' care.
One hundred and sixty villages will be randomized to deliver COACH or CAU to eligible subjects who reside there (approximately 15 per village will meet criteria), or a total of about 2400 subjects. Treatment will continue for one year, with research evaluations at baseline, 3 6, 9, and 12 months.
Specific aims of the study are to determine whether COACH is more effective than CAU in treating depression (Aim 1) and HTN (Aim 2); whether improvements in treatment adherence precede reductions in depression and improvement in BP control (Aim 3a), and whether improvements in depression symptoms precede improvements in BP control (Aim 3b); if COACH is associated with greater improvements in health related quality of life than CAU (Aim 4); and to compare the costs associated with each approach (Aim 5).
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Hangzhou, China, 310007
- Zhejiang Provincial Committee on Aging
-
Hangzhou, China, 310051
- Zhejiang Provincial Center for Disease Control and Prevention
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310058
- Zhejiang University
-
-
-
-
Louisiana
-
New Orleans, Louisiana, United States, 70112-2709
- Tulane University
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109-1274
- Regents of the University of Michigan
-
-
New York
-
Rochester, New York, United States, 14642
- University of Rochester Medical Center
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104-6205
- University of Pennsylvania
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Community-dwelling residents registered to the selected village, and thus also registered patients of the village's PCP.
- Age ≥ 60 years, the typical retirement age in rural China.
- Clinically significant depression defined as baseline PHQ-9 score ≥ 10.
- Diagnosis of hypertension
- Intact cognitive functioning (6-Item Screener score <3) to assure ability to participate with the treatment team in management of their conditions.
- Capable of independent communication
- Capacity to give informed consent.
Exclusion Criteria:
- Incapable (no capacity) of giving verbal consent to this study.
- Acute high suicide risk at baseline assessment. Patients assessed to be dangerously suicidal at later assessments will be discontinued from the study, their providers notified, and their safety guaranteed.
- Psychosis, alcoholism. We exclude patients with psychosis or active alcoholism in the past 6 months.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Care as usual
|
|
|
Experimental: Collaborations in Health (COACH)
COACH integrates the care provided by the older person's primary care provider (PCP) with that delivered by an Aging Worker (AW; a lay member of the village's Aging Association), supervised by a psychiatrist consultant.
Based on chronic disease management principles, the PCP is trained to use evidence based practice guidelines for treatment of both HTN and depression, and provided with access to mental health consultation regarding optimal management of the patient's depression.
The AW is trained to conduct a systematic assessment of the older person's social context to identify and reduce social and environmental barriers to treatment adherence and response.
AWs participate with the PCP in developing multi-disciplinary care plans for their shared patients, reinforce treatment adherence and adoption of healthy behaviors, and emphasize activation and engagement of the older person in activities designed to improve their connectedness to others and to the community.
|
Primary care provider, aging worker, and Psychiatrist Consultant are trained to collaborate in their shared clients' care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Depressive symptom change
Time Frame: baseline, 3-, 6-, and 12-month follow up
|
The measure for depressive symptom change will be the Hamilton Depression Rating Scale.
|
baseline, 3-, 6-, and 12-month follow up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Adherence to antidepressant and antihypertensive medication recommendations
Time Frame: baseline, 3-, 6-, 9-, and 12-month follow up
|
First, the Morisky Medication Adherence Measure will be used.
Secondly, a Medication Possession Ratio will be used-a combination of pill counts and verification of pharmacy refills.
|
baseline, 3-, 6-, 9-, and 12-month follow up
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hypertension
Time Frame: baseline, 3-, 6-, 9-, and 12-month follow-up
|
Blood pressure readings will be taken at baseline and at follow-ups.
|
baseline, 3-, 6-, 9-, and 12-month follow-up
|
|
Health related quality of life
Time Frame: baseline, 3-, 6-, 9-, and 12-month follow up
|
Quality of life will be measured using the World Health Organization Quality of Life- short version, WHOQOL-BREF. Satisfaction will be measured with the Client Satisfaction Questionnaire 8-item. |
baseline, 3-, 6-, 9-, and 12-month follow up
|
|
Costs associated with the intervention
Time Frame: baseline, 3-, 6-, 9-, and 12-month follow-up
|
Two components will be evaluated: program costs associated with adding resources to care as usual, and medical costs attributed to the care of the subjects in each arm.
|
baseline, 3-, 6-, 9-, and 12-month follow-up
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Shulin Chen, MD, PhD, Zhejiang University, Department of Psychology
Publications and helpful links
General Publications
- Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003 May 21;289(19):2560-72. doi: 10.1001/jama.289.19.2560. Epub 2003 May 14. Erratum In: JAMA. 2003 Jul 9;290(2):197.
- Chen S, Conwell Y, Xue J, Li L, Zhao T, Tang W, Bogner H, Dong H. Effectiveness of integrated care for older adults with depression and hypertension in rural China: A cluster randomized controlled trial. PLoS Med. 2022 Oct 24;19(10):e1004019. doi: 10.1371/journal.pmed.1004019. eCollection 2022 Oct.
- Chen S, Conwell Y, Xue J, Li LW, Tang W, Bogner HR, Dong H. Protocol of an ongoing randomized controlled trial of care management for comorbid depression and hypertension: the Chinese Older Adult Collaborations in Health (COACH) study. BMC Geriatr. 2018 May 29;18(1):124. doi: 10.1186/s12877-018-0808-1.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01MH100298-01 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
Massachusetts General HospitalRecruitingDepression | Depression - Major Depressive Disorder | Depression Chronic | Depression in Adults | Depression Disorders | Depression DisorderUnited States
-
University of California, San FranciscoNational Center for Complementary and Integrative Health (NCCIH)Active, not recruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
ProgenaBiomeWithdrawnDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; Australian Catholic University; Helse...RecruitingAnxiety | Anxiety Depression | Depression Anxiety Disorder | Depression - Major Depressive DisorderNorway
-
Lipocine Inc.CompletedDepression, Postpartum | Postnatal Depression | Peripartum Depression | Depression, Post-Partum | Postpartum Depression (PPD) | Post-Natal DepressionUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryActive, not recruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Kolby Walker, DO; Brittany KimbleRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of CincinnatiNational Center for Complementary and Integrative Health (NCCIH)RecruitingMild DepressionUnited States
-
University of MinnesotaCompletedDepression SymptomsUnited States
Clinical Trials on Collaborations in Health (COACH)
-
Tulane UniversityUniversity of Pennsylvania; National Heart, Lung, and Blood Institute (NHLBI); Pennington Biomedical Research CenterRecruitingHyperglycemia | Obesity | PreDiabetes | Gestational Diabetes | Glucose Intolerance During Pregnancy | Lifestyle, HealthyUnited States
-
Dartmouth-Hitchcock Medical CenterPatient-Centered Outcomes Research Institute; Trustees of Dartmouth CollegeCompleted
-
Vanderbilt University Medical CenterRecruitingChildhood ObesityUnited States
-
Taipei Medical UniversityMinistry of Science and Technology, TaiwanCompleted
-
University of Texas Southwestern Medical CenterUnlocking DoorsRecruitingThe Unlocking PrEP Study: Integration of Peer Health Navigation Into Comprehensive Re-entry ServicesHIV Prevention | HIV DiseaseUnited States
-
Clinical Directors NetworkPatient-Centered Outcomes Research InstituteRecruitingSelf-Management | ComorbidityUnited States
-
Wake Forest University Health SciencesTerminatedEpilepsy | Refractory EpilepsyUnited States
-
Women's College HospitalRecruiting
-
Emory UniversityAmerican Heart AssociationCompletedCardiovascular DiseasesUnited States